RESULT_COUNT: 230,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
AVXS,AVXS:UW,BBG00BWQPDY9,Edited Transcript of AVXS earnings conference call or presentation 16-Mar-17 8:30pm GMT,2017-10-17 11:25:34 +0000,https://finance.yahoo.com/news/edited-transcript-avxs-earnings-conference-105747141.html?.tsrc=rss,Q4 2016 AveXis Inc Earnings Call
AVXS,AVXS:UW,BBG00BWQPDY9,Nuclear clean-up robot tested at Sellafield and Fukushima,2017-10-13 14:52:23 +0000,https://www.yahoo.com/news/nuclear-clean-robot-tested-sellafield-145223517.html?.tsrc=rss,An aquatic robot called Avexis is being tested in Japan ahead of being deployed into the damaged core of the Fukushima Daiichi Nuclear Power Plant. Matthew Stock reports.
AVXS,AVXS:UW,BBG00BWQPDY9,Nuclear clean-up robot tested at Sellafield and Fukishima,2017-10-13 14:05:42 +0000,https://www.yahoo.com/tech/nuclear-clean-robot-tested-sellafield-140542645.html?.tsrc=rss,An aquatic robot called Avexis is being tested in Japan ahead of being deployed into the damaged core of the Fukushima Daiichi Nuclear Power Plant. Matthew Stock reports.
AVXS,AVXS:UW,BBG00BWQPDY9,"Why PTC Therapeutics, Inc. Dropped Today",2017-10-03 21:33:00 +0000,http://finance.yahoo.com/r/cfed4fb0-30f7-3db5-9176-40b532e6b6fd/why-ptc-therapeutics-inc-dropped-today.aspx?yptr=yahoo&.tsrc=rss,Investors are unimpressed with data -- so far -- for the biotech&apos;s spinal muscular atrophy drug RG7916.
AVXS,AVXS:UW,BBG00BWQPDY9,"AveXis Flies, But PTC Sinks On Spinal Muscular Atrophy Data",2017-10-03 20:25:36 +0000,http://finance.yahoo.com/r/c21c4ebf-956b-3bc6-bd86-4f330633b70d/avexis-flies-but-ptc-sinks-on-spinal-muscular-atrophy-data?src=A00220&yptr=yahoo&.tsrc=rss,"AveXis touched a record high Tuesday, but PTC dove by double digits as each biotech presented updates on their spinal muscular atrophy programs."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis to Report Top-line Data from the Phase 1 Clinical Trial of AVXS-101 in SMA Type 1 at the International Annual Congress of the World Muscle Society,2017-10-03 12:00:00 +0000,https://finance.yahoo.com/news/avexis-report-top-line-data-120000407.html?.tsrc=rss,"–All patients were alive and event-free at 20 months of age as of the August 7, 2017 data cut-off–. –Patients in Cohort 2 continue to demonstrate improvements in motor milestones–. SAINT MALO, France, ..."
AVXS,AVXS:UW,BBG00BWQPDY9,Featured Company News - AveXis Intends To Initiate Pivotal Trial Of AVXS-101 In SMA Type 1 On An Immediate Basis,2017-10-03 11:20:00 +0000,https://finance.yahoo.com/news/featured-company-news-avexis-intends-112000257.html?.tsrc=rss,"LONDON, UK / ACCESSWIRE / October 3, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for AveXis, Inc. (NASDAQ: AVXS ), following which we have published ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"ZGNX Leaps On Trial Data, NVO Gets It Right The 2nd Time, MNKD On Watch",2017-10-01 21:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eX4FB-2MPw4/zgnx-leaps-on-trial-data-nvo-gets-it-right-the-2nd-time-mnkd-on-watch-20171001-00040,"ZGNX Leaps On Trial Data, NVO Gets It Right The 2nd Time, MNKD On Watch"
AVXS,AVXS:UW,BBG00BWQPDY9,"Health Care Sector Update for 09/29/2017: PTCT,AVXS,NNVC",2017-09-29 19:33:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yiEw1LCM1l8/health-care-sector-update-for-09292017-ptctavxsnnvc-cm853261,Top Health Care StocksTop Health Care Stocks JNJ 0 17 JNJ 0 17 PFE 0 03 PFE 0 03 ABT 0 54 ABT 0 54 MRK 0 72 MRK 0 72 AMGN 0 28 AMGN 0 28 Health care stocks were holding modest gains this afternoon with the NYSE Health Care Index rising almost 0 3 while shares of health
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis: Now That's a Go Ahead!,2017-09-29 15:48:00 +0000,http://finance.yahoo.com/r/ed98a6ed-f4ed-3cc0-8a43-4f2941546d87/avexis-now-thats-a-go-ahead-1506700079?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"AveXis (AVXS), a leading gene-therapy company, is up 9.5% to $100.97 today after announcing this morning that the Food and Drug Administration will allow it to go forward with a pivotal clinical trial for its promising treatment for spinal muscular atrophy (SMA) after reviewing the company’s manufacturing capabilities.  AveXis said it “plans to initiate this trial immediately.” The shares hit a record $101.67 earlier today.  The iShares Biotechnology ETF (IBB) has ticked up 0.1% to $330.88."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Announces Plan to Initiate Pivotal Trial of AVXS-101 in SMA Type 1 Using Product from New GMP Commercial Process,2017-09-29 11:00:00 +0000,https://finance.yahoo.com/news/avexis-announces-plan-initiate-pivotal-110000590.html?.tsrc=rss,–FDA notified AveXis it may initiate pivotal trial based on a review of data provided by the company following CMC Type B meeting–. –Product used in the pivotal trial will be from the AveXis GMP manufacturing ...
AVXS,AVXS:UW,BBG00BWQPDY9,Gene Therapy: A Big Week for Many Names,2017-09-25 14:47:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cdGvwJIxtoE/gene-therapy-a-big-week-for-many-names-cm850359,It s been a big week for the gene therapy universe It s been a big week for the gene therapy universe Of course there s the latest Barron s cover story which details the emerging medical revolution and highlights three stocks AveXis AVXS Regenxbio RGNX and Spark
AVXS,AVXS:UW,BBG00BWQPDY9,[$$] Gene Therapy Is Nearing a Major Breakthrough,2017-09-25 04:01:00 +0000,http://finance.yahoo.com/r/0cc44cf1-ce16-3c9e-85bb-26fdfbce3cc5/gene-therapy-is-nearing-a-major-breakthrough-1506140340?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"After decades of research and development, gene therapy is rapidly emerging as one of the most exciting areas in biotechnology—and generating new hope for patients with certain rare and often deadly inherited diseases.  Replacement gene therapy that uses neutered viruses to deliver healthy genes to the body is particularly promising, given its potential to cure a range of disorders with the administration of a single treatment.  The first regulatory approval for this technology could come as soon as January, if the Food and Drug Administration gives the go-ahead to Spark Therapeutics (ONCE) for its one-time treatment that targets a rare, inherited retinal condition leading to blindness."
AVXS,AVXS:UW,BBG00BWQPDY9,Edited Transcript of AVXS earnings conference call or presentation 10-Aug-17 8:30pm GMT,2017-09-15 17:41:01 +0000,https://finance.yahoo.com/news/edited-transcript-avxs-earnings-conference-025647461.html?.tsrc=rss,Q2 2017 AveXis Inc Earnings Call
AVXS,AVXS:UW,BBG00BWQPDY9,"Notable Thursday Option Activity: NFLX, AVXS, ICPT",2017-09-14 16:40:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3ivoG6cYpwA/notable-thursday-option-activity-nflx-avxs-icpt-cm845773,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Netflix Inc Symbol NFLX where a total of 30 200 contracts have traded so far representing approximately 3 0 million underlying shares That amounts to about 53 4 of NFLX s
AVXS,AVXS:UW,BBG00BWQPDY9,Breaking Down Barclays' New Bullish Calls On Biotech,2017-09-07 19:32:52 +0000,https://finance.yahoo.com/news/breaking-down-barclays-bullish-calls-193252995.html?.tsrc=rss,"Barclays initiated coverage of the U.S. small- and mid-cap biotechnology industry with a Positive view, as it expects the outperformance of the sector relative to the S&P 500 to continue in the next 12-18 ..."
AVXS,AVXS:UW,BBG00BWQPDY9,Look Under The Hood: VTWG Has 11% Upside,2017-08-31 14:49:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kDMsmpSFUcI/look-under-the-hood-vtwg-has-11-upside-cm839621,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
AVXS,AVXS:UW,BBG00BWQPDY9,"ACHV Focuses On Achievement, IMGN Strikes Chord With JAZZ, FDA Snubs ACOR",2017-08-29 23:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NveLk96LAXw/achv-focuses-on-achievement-imgn-strikes-chord-with-jazz-fda-snubs-acor-20170829-01275,"ACHV Focuses On Achievement, IMGN Strikes Chord With JAZZ, FDA Snubs ACOR"
AVXS,AVXS:UW,BBG00BWQPDY9,"Commit To Purchase AveXis At $80, Earn 16.5% Annualized Using Options",2017-08-23 16:38:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jKw9T14aCcE/commit-to-purchase-avexis-at-80-earn-165-annualized-using-options-cm835995,Investors eyeing a purchase of AveXis Inc Symbol AVXS shares but cautious about paying the going market price of 96 47 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the February 2018 put
AVXS,AVXS:UW,BBG00BWQPDY9,"Boxer Capital, LLC Buys Macrogenics Inc, G1 Therapeutics Inc, iPath S&P 500 VIX Short Term ...",2017-08-15 20:35:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CeIaXgeW0OY/boxer-capital-llc-buys-macrogenics-inc-g1-therapeutics-inc-ipath-sp-500-vix-short-term-cm832468,Boxer Capital LLC New Purchases MGNX GTHX VXX Added Positions PTCT LJPC SNSS SGEN Reduced Positions CLVS BPMC AVXS ESPR BGNE AQXP CBAY ONTX Sold Out ALNY ALXN ALDX ANAB AKTX ARDM NVET New Purchases MGNX
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis reports 2Q loss,2017-08-11 01:15:17 +0000,https://finance.yahoo.com/news/avexis-reports-2q-loss-201409495.html?.tsrc=rss,"The Bannockburn, Illinois-based company said it had a loss of $2.07 per share. The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research ..."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Reports Second Quarter 2017 Financial and Operating Results,2017-08-10 20:01:00 +0000,https://finance.yahoo.com/news/avexis-reports-second-quarter-2017-200100247.html?.tsrc=rss,"–AveXis on track to submit potency assay data to FDA in August–. –Conference call and webcast August 10 at 4:30 p.m. EDT–. CHICAGO, Aug. 10, 2017-- AveXis, Inc., a clinical-stage gene therapy company developing ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"After-Hours Earnings Report for August 10, 2017 :  NVDA, JWN, PBR, NWSA, AZPN, AVXS, PCTY, LXFT, EPAY, NH, UPLD, CBAY",2017-08-10 18:49:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XEgLCUsj0vQ/after-hours-earnings-report-for-august-10-2017-nvda-jwn-pbr-nwsa-azpn-avxs-pcty-lxft-epay-nh-upld-cbay-cm830426,The following companies are expected to report earnings after hours on 08 10 2017 Visit our Earnings Calendar for a full list of expected earnings releases NVIDIA Corporation NVDA is reporting for the quarter ending July 31 2017 The semiconductor company
AVXS,AVXS:UW,BBG00BWQPDY9,[$$] Zinsli's Take: Biotech's Saviors Keep Up VCs' Hopes,2017-08-09 11:30:03 +0000,http://finance.yahoo.com/r/7c99ff67-bcdc-3d95-8f2f-1cf2716d6bfe/zinslis-take-biotechs-saviors-keep-up-vcs-hopes-1502278200?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Venture investors in biotechnology are relying heavily on the public markets to deliver returns, but their hopes are pinned to the strong results of an exceedingly small number of post-IPO companies."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis to Report Second Quarter 2017 Financial and Operating Results,2017-08-03 12:00:00 +0000,https://finance.yahoo.com/news/avexis-report-second-quarter-2017-120000924.html?.tsrc=rss,"CHICAGO, Aug. 03, 2017-- AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, will report financial ..."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Inc.: Buy at the High?,2017-07-18 14:04:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aAv3kl7RMO8/avexis-inc-buy-at-the-high-cm817311,In the time it takes most newborns to sprout their first teeth AveXis Inc NASDAQ AVXS looks ready to sink its teeth into the biotech industry Since its market debut in early 2016 stellar clinical trial results for its lead candidate have propelled the stock about 349
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Inc.: Buy at the High?,2017-07-18 12:42:00 +0000,http://finance.yahoo.com/r/236791dc-f58c-3189-9d37-9137d2327500/avexis-inc-buy-at-the-high.aspx?yptr=yahoo&.tsrc=rss,"Stellar clinical-trial results have pushed AveXis Inc. stock to an all-time high. Is the stock still a buy at recent prices, or should you wait for a pullback?"
AVXS,AVXS:UW,BBG00BWQPDY9,3 Stocks at All-Time Highs Still Worth Buying,2017-07-08 12:44:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H4wgPvO752Q/3-stocks-at-all-time-highs-still-worth-buying-cm813401,It seems logical to try to purchase shares of a stock after it has declined To be sure Buy low sell high is an oft repeated mantra among value seeking investors But keeping in mind there s usually a good reason behind the declines of most stocks experienced investors know
AVXS,AVXS:UW,BBG00BWQPDY9,3 Stocks at All-Time Highs Still Worth Buying,2017-07-08 11:28:00 +0000,http://finance.yahoo.com/r/a2a31c45-1c36-3a50-8a75-36237c438fd0/3-stocks-at-all-time-highs-still-worth-buying.aspx?yptr=yahoo&.tsrc=rss,Don&apos;t be afraid of their lofty share prices. These winners should keep on winning.
AVXS,AVXS:UW,BBG00BWQPDY9,4 Reasons the AveXis Inc. Rally Could Continue,2017-07-01 17:42:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4clvVsXPdbo/4-reasons-the-avexis-inc-rally-could-continue-cm810889,AveXis Inc NASDAQ AVXS shareholders have enjoyed a 103 gain over the past year and a stunning 333 gain since the clinical stage biotech made its debut as a publicly traded company in early 2016 Despite the terrific run up there are at least four reasons the rally could
AVXS,AVXS:UW,BBG00BWQPDY9,4 Reasons the AveXis Inc. Rally Could Continue,2017-07-01 15:41:00 +0000,http://finance.yahoo.com/r/e0ad6191-1382-3bc8-8502-56079da6115d/4-reasons-the-avexis-inc-rally-could-continue.aspx?yptr=yahoo&.tsrc=rss,AveXis Inc. stock has more than doubled over the past year. Here&apos;s why it could climb even further.
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares,2017-06-26 20:00:00 +0000,https://finance.yahoo.com/news/avexis-announces-closing-public-offering-200000633.html?.tsrc=rss,"CHICAGO, June 26, 2017-- AveXis, Inc. today announced the closing of its previously announced underwritten public offering of 4,111,250 shares of its common stock at a price to the public of $70.00 per ..."
AVXS,AVXS:UW,BBG00BWQPDY9,3 Stocks You Probably Never Heard Of Could Catch Fire Soon,2017-06-22 15:03:00 +0000,http://finance.yahoo.com/r/fad7b126-1224-3556-b907-fa98f055f2ce/smart-money-footprints-in-the-charts-for-twitter-advanced-micro-devices-and-more.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Six charts showing signs of smart money footprints.
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis (AVXS) Jumps: Stock Rises 7.1%,2017-06-22 14:25:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tpLGoN6OPQE/avexis-avxs-jumps-stock-rises-71-cm806768,AveXis Inc AVXS was a big mover last session as the company saw its shares rise over 7 on the day The move came on solid volume too with far more shares changing hands than in a normal session This stock which remained volatile and traded within the range of 67 48 80 34 in the
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis (AVXS) Jumps: Stock Rises 7.1%,2017-06-22 12:35:12 +0000,https://finance.yahoo.com/news/avexis-avxs-jumps-stock-rises-123512003.html?.tsrc=rss,"AveXis, Inc.(AVXS) was a big mover last session, as the company saw its shares rise over 7% on the day."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Announces Pricing of Public Offering of Common Stock,2017-06-21 01:15:23 +0000,https://finance.yahoo.com/news/avexis-announces-pricing-public-offering-011523239.html?.tsrc=rss,"CHICAGO, June 20, 2017-- AveXis, Inc. today announced the pricing of an underwritten public offering of 3,575,000 shares of its common stock. The net proceeds to AveXis from the offering, after deducting ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"Biotech Movers: AveXis, Clovis, Epizyme",2017-06-20 13:33:00 +0000,http://finance.yahoo.com/r/b227c02e-9b38-3d18-8cfb-acbc7218c425/biotech-movers-avexis-clovis-epizyme.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"AveXis, Clovis Oncology and Epizyme were among the biotech stock movers in premarket trading on June 20."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Announces Proposed Public Offering of Common Stock,2017-06-19 20:00:00 +0000,https://finance.yahoo.com/news/avexis-announces-proposed-public-offering-200000774.html?.tsrc=rss,"CHICAGO, June 19, 2017-- AveXis, Inc. today announced that it intends to offer and sell, subject to market conditions, up to $200 million of shares of its common stock in an underwritten public offering. ..."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis (AVXS) Surges: Stock Moves 5% Higher,2017-06-19 14:25:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wUSE4UC2x2g/avexis-avxs-surges-stock-moves-5-higher-cm804950,AveXis Inc AVXS was a big mover last session as the company saw its shares rise over 5 on the day The move came on solid volume too with far more shares changing hands than in a normal session This stock which remained volatile and traded within the range of 67 48 80 34 in the
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis (AVXS) Surges: Stock Moves 5% Higher,2017-06-19 12:34:12 +0000,https://finance.yahoo.com/news/avexis-avxs-surges-stock-moves-123412052.html?.tsrc=rss,"AveXis (AVXS) was a big mover last session, as the company saw its shares rise over 5% on the day."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Announces Alignment with FDA on GMP Commercial Manufacturing Process for AVXS-101,2017-06-14 20:00:00 +0000,https://finance.yahoo.com/news/avexis-announces-alignment-fda-gmp-200000831.html?.tsrc=rss,–Agency is supportive of proposed analytical methods and comparability protocol–. SMA Type 1 and Type 2 trials in Q3 2017 with product from new process–. –AveXis manufacturing facility is fully operational ...
AVXS,AVXS:UW,BBG00BWQPDY9,REGENXBIO and AveXis Announce New Exclusive Worldwide Licenses for the Treatment of Two Rare Neurological Monogenic Disorders Using NAV AAV9 Vector,2017-06-07 20:01:00 +0000,https://finance.yahoo.com/news/regenxbio-avexis-announce-exclusive-worldwide-200100304.html?.tsrc=rss,"ROCKVILLE, Md. and CHICAGO, Ill., June 07, 2017-- REGENXBIO Inc. and AveXis, Inc. today announced an exclusive worldwide license agreement for AveXis to develop and commercialize gene therapy treatments ..."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis and REGENXBIO Announce New Exclusive Worldwide Licenses for the Treatment of Two Rare Neurological Monogenic Disorders Using NAV AAV9 Vector,2017-06-07 20:00:00 +0000,https://finance.yahoo.com/news/avexis-regenxbio-announce-exclusive-worldwide-200000248.html?.tsrc=rss,"CHICAGO and ROCKVILLE, Md., June 07, 2017-- AveXis, Inc. and REGENXBIO Inc. today announced an exclusive worldwide license agreement for AveXis to develop and commercialize gene therapy treatments using ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"Top Gainers in the Healthcare Sector: May 22–26, 2017",2017-05-31 16:01:33 +0000,http://finance.yahoo.com/r/c545af3c-e484-35a8-81a4-38a8c1e58953/top-gainers-in-the-healthcare-sector-may-22-26-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"From May 19–May 26, 2017, pharmaceutical company Puma Biotechnology (PBYI) witnessed a rise of 111% in its stock price."
AVXS,AVXS:UW,BBG00BWQPDY9,"What Falling Estimates & Price Mean for AveXis, Inc. (AVXS)",2017-05-18 14:16:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P5IEqC8Ide4/what-falling-estimates-price-mean-for-avexis-inc-avxs-cm791245,Similar to wise buying decisions exiting certain underperformers at the right time helps maximize portfolio returns Selling off losers can be difficult but if both the share price and estimates are falling it could be time to get rid of the security before more losses hit your portfolio
AVXS,AVXS:UW,BBG00BWQPDY9,"What Falling Estimates & Price Mean for AveXis, Inc. (AVXS)",2017-05-18 12:38:12 +0000,https://finance.yahoo.com/news/falling-estimates-price-mean-avexis-123812832.html?.tsrc=rss,"It seems wise to sell the AveXis, Inc. (AVXS) stock at this moment as its both estimates and price have been witnessing downward revision."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis reports 1Q loss,2017-05-11 21:50:43 +0000,http://finance.yahoo.com/news/avexis-reports-1q-loss-215043197.html?.tsrc=rss,"On a per-share basis, the Bannockburn, Illinois-based company said it had a loss of $1.07. The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"Noteworthy Thursday Option Activity: BA, RL, AVXS",2017-05-11 21:01:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hdzFsTHYp-g/noteworthy-thursday-option-activity-ba-rl-avxs-cm788141,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Boeing Co Symbol BA where a total volume of 12 293 contracts has been traded thus far today a contract volume which is representative of approximately 1 2 million
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Reports First Quarter 2017 Financial and Operating Results,2017-05-11 20:00:00 +0000,http://finance.yahoo.com/news/avexis-reports-first-quarter-2017-200000433.html?.tsrc=rss,"CHICAGO, May 11, 2017-- AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today reported financial ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"After-Hours Earnings Report for May 11, 2017 :  CA, JWN, STN, DAR, AVXS, CYBR, HOLI, BLBD, UPLD, MCFT, AST, KINS",2017-05-11 19:01:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w-tOcLJ-R_M/after-hours-earnings-report-for-may-11-2017-ca-jwn-stn-dar-avxs-cybr-holi-blbd-upld-mcft-ast-kins-cm788084,The following companies are expected to report earnings after hours on 05 11 2017 Visit our Earnings Calendar for a full list of expected earnings releases CA Inc CA is reporting for the quarter ending March 31 2017 The computer software company
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis to Report First Quarter 2017 Financial and Operating Results,2017-05-04 12:00:00 +0000,http://finance.yahoo.com/news/avexis-report-first-quarter-2017-120000949.html?.tsrc=rss,"CHICAGO, May 04, 2017-- AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, will report financial ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"Notable Wednesday Option Activity: OLLI, AVXS, SMG",2017-04-26 20:44:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DcLe4ydDiuU/notable-wednesday-option-activity-olli-avxs-smg-cm779856,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Ollie s Bargain Outlet Holdings Inc Symbol OLLI where a total volume of 5 160 contracts has been traded thus far today a contract volume which is representative
AVXS,AVXS:UW,BBG00BWQPDY9,High-Stakes Meeting Between Avexis and FDA Will Set the Course for Gene Therapy and Dying Kids,2017-04-26 11:42:00 +0000,http://finance.yahoo.com/r/e8ddc571-1e8a-3adb-a14c-0903b337279c/high-stakes-meeting-between-avexis-and-fda-will-set-the-course-for-gene-therapy-and-dying-kids.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Investors focus on a drug's efficacy and safety. Much less time is spent considering the importance of manufacturing, even though it is a vital step in the drug approval process."
AVXS,AVXS:UW,BBG00BWQPDY9,InPlay from Briefing.com,2017-04-25 14:55:10 +0000,http://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Presents Results from Phase 1 Trial of AVXS-101 in SMA Type 1 at the Annual Meeting of the American Academy of Neurology,2017-04-25 14:33:53 +0000,http://finance.yahoo.com/news/avexis-presents-results-phase-1-143353737.html?.tsrc=rss,–10 of 12 patients on proposed therapeutic dose sat unassisted; patient videos demonstrate motor milestone achievement not seen in natural history of disease–. –86% of patients without feeding support ...
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis to Host Webcast of Preclinical and Clinical Studies of AVXS-101 as Presented at the Annual Meeting of the American Academy of Neurology,2017-04-18 12:00:00 +0000,http://finance.yahoo.com/news/avexis-host-webcast-preclinical-clinical-120000020.html?.tsrc=rss,"–Includes Results from Phase 1 Trial of AVXS-101 in SMA Type 1–. –Conference call and webcast Tuesday, April 25 at 4:30 p.m. EDT–. CHICAGO, April 18, 2017-- AveXis, Inc., a clinical-stage gene therapy ..."
AVXS,AVXS:UW,BBG00BWQPDY9,Which Biotechs Are Buyable As Sector Recovers In 2017?,2017-03-30 20:08:02 +0000,http://www.investors.com/news/technology/which-biotechs-are-buyable-as-sector-recovers-in-2017/?src=A00220A,Which Biotechs Are Buyable As Sector Recovers In 2017?
AVXS,AVXS:UW,BBG00BWQPDY9,Which Biotechs Are Buyable As Sector Recovers In 2017?,2017-03-30 20:08:02 +0000,http://finance.yahoo.com/r/c19d435e-c5ae-321e-b275-2c2857e8deb4/which-biotechs-are-buyable-as-sector-recovers-in-2017?src=A00220A&yptr=yahoo&.tsrc=rss,"Biotech stocks have outperformed major indexes in 2017 and, on Thursday, a slew grabbed buy ratings."
AVXS,AVXS:UW,BBG00BWQPDY9,Coverage initiated on AveXis by UBS,2017-03-30 13:23:10 +0000,http://finance.yahoo.com/q/ud?s=AVXS,Coverage initiated on AveXis by UBS
AVXS,AVXS:UW,BBG00BWQPDY9,"AVEXIS, INC. Financials",2017-03-23 17:04:12 +0000,http://finance.yahoo.com/q/is?s=avxs,"AVEXIS, INC. Financials"
AVXS,AVXS:UW,BBG00BWQPDY9,Cytokinetics SMA Drug Did Well in Early Study,2017-03-22 19:10:00 +0000,http://finance.yahoo.com/r/5fde6a56-de77-3033-b86e-a00d416750a1/cytokinetics-sma-drug-did-well-early-study-cytk?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Cytokinetics' spinal muscular atrophy drug, CK-2127107, improved muscle function in a pre-clinical study."
AVXS,AVXS:UW,BBG00BWQPDY9,Cytokinetics SMA Drug Did Well in Early Study,2017-03-22 19:10:00 +0000,http://www.investopedia.com/news/cytokinetics-sma-drug-did-well-early-study-cytk/?partner=YahooSA,Cytokinetics SMA Drug Did Well in Early Study
AVXS,AVXS:UW,BBG00BWQPDY9,Billionaires' Best Healthcare Stock Picks of 2017 (So Far),2017-03-21 19:02:00 +0000,http://finance.yahoo.com/r/9f08b028-c429-393a-9ff5-1ffec2af0934/billionaires-best-healthcare-stock-picks-of-2017-s.aspx?yptr=yahoo&.tsrc=rss,"Why billionaire investors are loving Immunomedics, Achaogen, AveXis, Exact Sciences, and Clovis Oncology this year."
AVXS,AVXS:UW,BBG00BWQPDY9,Billionaires' Best Healthcare Stock Picks of 2017 (So Far),2017-03-21 19:02:00 +0000,https://www.fool.com/investing/2017/03/21/billionaires-best-healthcare-stock-picks-of-2017-s.aspx,Billionaires' Best Healthcare Stock Picks of 2017 (So Far)
AVXS,AVXS:UW,BBG00BWQPDY9,"AveXis, Inc. (AVXS) Looks Good: Stock Moves 15.4% Higher",2017-03-20 14:09:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6IW2Nkoidfg/avexis-inc-avxs-looks-good-stock-moves-154-higher-cm762741,AveXis Inc AVXS was a big mover last session as the company saw its shares rise above 15 on the day The upside was due to continuation of the rally triggered by the announcement of Phase 1 trial of AVXS 101 in spinal muscular atrophy SMA Type 1 Also this led to far more shares
AVXS,AVXS:UW,BBG00BWQPDY9,"AveXis, Inc. (AVXS) Looks Good: Stock Moves 15.4% Higher",2017-03-20 12:20:12 +0000,http://finance.yahoo.com/news/avexis-inc-avxs-looks-good-122012222.html?.tsrc=rss,"AveXis, Inc. (AVXS) shares rise above 15% in the last trading session."
AVXS,AVXS:UW,BBG00BWQPDY9,"AveXis, Inc. (AVXS) Looks Good: Stock Moves 15.4% Higher",2017-03-20 12:20:12 +0000,http://finance.yahoo.com/news/avexis-inc-avxs-looks-good-122012222.html,"AveXis, Inc. (AVXS) Looks Good: Stock Moves 15.4% Higher"
AVXS,AVXS:UW,BBG00BWQPDY9,"Notable Friday Option Activity: STZ, AVXS, GNMX",2017-03-17 21:06:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IVOFQ2Aptro/notable-friday-option-activity-stz-avxs-gnmx-cm762423,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Constellation Brands Inc Symbol STZ where a total of 8 527 contracts have traded so far representing approximately 852 700 underlying shares That amounts to about 49 1 of STZ
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Inc Stock Is Spiking Again Today -- Here's Why,2017-03-17 17:06:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8XeRZwRxVLo/avexis-inc-stock-is-spiking-again-today-heres-why-cm762301,What happened Shares of AveXis Inc NASDAQ AVXS a clinical stage biotech company developing gene therapies are adding to a tremendous run up this year with a 16 8 gain as of 11 30 a m EDT during Friday s session Yesterday afternoon the company included phase 1 trial data
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Inc Stock Is Spiking Again Today -- Here's Why,2017-03-17 15:44:00 +0000,https://www.fool.com/investing/2017/03/17/avexis-inc-stock-is-spiking-again-today-heres-why.aspx,AveXis Inc Stock Is Spiking Again Today -- Here's Why
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Inc Stock Is Spiking Again Today -- Here's Why,2017-03-17 15:44:00 +0000,http://finance.yahoo.com/r/a3a340b7-9a55-3ce1-a087-4a71920bf288/avexis-inc-stock-is-spiking-again-today-heres-why.aspx?yptr=yahoo&.tsrc=rss,Fourth-quarter earnings included a clinical trial update that has Biogen and Ionis Pharmaceuticals investors nervous.
AVXS,AVXS:UW,BBG00BWQPDY9,"AveXis, Esperion and Amgen Among Biotech Movers",2017-03-17 15:03:00 +0000,http://finance.yahoo.com/r/d0065230-449a-37a1-a801-70aa4119c150/avexis-esperion-and-amgen-among-biotech-movers.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"AveXis, Esperion Therapeutics, Medicines Co. and Amgen were among the biotech stock movers Friday morning."
AVXS,AVXS:UW,BBG00BWQPDY9,"[video]AveXis, Esperion and Amgen Among Biotech Movers",2017-03-17 15:03:00 +0000,https://www.thestreet.com/story/14049078/1/avexis-esperion-and-amgen-among-biotech-movers.html?puc=yahoo&cm_ven=YAHOO,"[video]AveXis, Esperion and Amgen Among Biotech Movers"
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Reports Positive Data for SMA Gene Therapy,2017-03-17 14:25:00 +0000,http://www.investopedia.com/news/avexis-sma-gene-drug-reports-positive-data-avxs/?partner=YahooSA,AveXis Reports Positive Data for SMA Gene Therapy
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Reports Positive Data for SMA Gene Therapy,2017-03-17 14:25:00 +0000,http://finance.yahoo.com/r/e8ce9b8d-5315-3a31-84f7-0382a5aa767a/avexis-sma-gene-drug-reports-positive-data-avxs?partner=YahooSA&yptr=yahoo&.tsrc=rss,"AveXis' spinal muscular atrophy drug, AVXS-101, reported encouraging results from a Phase 1 trial."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Offers Easily The Best Treatment Option For SMA Type-1 Patients,2017-03-17 13:53:16 +0000,http://finance.yahoo.com/news/avexis-offers-easily-best-treatment-135316896.html,AveXis Offers Easily The Best Treatment Option For SMA Type-1 Patients
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Offers Easily The Best Treatment Option For SMA Type-1 Patients,2017-03-17 13:53:16 +0000,http://finance.yahoo.com/news/avexis-offers-easily-best-treatment-135316896.html?.tsrc=rss,"AveXis Inc (NASDAQ: AVXS ) announced top-line data from the phase I study for AVXS-101, an AAV  -based gene therapy , for spinal muscular atrophy  type 1. AVXS-101 could ..."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Holding On To Substantial Gain In Afternoon Trading,2017-03-17 13:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hA-4bbOxIkw/avexis-holding-on-to-substantial-gain-in-afternoon-trading-20170317-00677,AveXis Holding On To Substantial Gain In Afternoon Trading
AVXS,AVXS:UW,BBG00BWQPDY9,"Stock Futures Hold Gains; Adobe, Tiffany, Steel Dynamics Climb",2017-03-17 12:48:22 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-hold-tight-gains-boing-pops-on-apache-contract/?src=A00220A,"Stock Futures Hold Gains; Adobe, Tiffany, Steel Dynamics Climb"
AVXS,AVXS:UW,BBG00BWQPDY9,PBM Capital Group has completed the sale of a majority interest in Breas Medical Group to Fosun Pharma,2017-03-17 12:00:00 +0000,http://uk.finance.yahoo.com/news/pbm-capital-group-completed-sale-120000733.html,PBM Capital Group has completed the sale of a majority interest in Breas Medical Group to Fosun Pharma
AVXS,AVXS:UW,BBG00BWQPDY9,Edited Transcript of AVXS earnings conference call or presentation 16-Mar-17 8:30pm GMT,2017-03-17 10:57:47 +0000,http://finance.yahoo.com/news/edited-transcript-avxs-earnings-conference-105747141.html?.tsrc=rss,Q4 2016 AveXis Inc Earnings Call
AVXS,AVXS:UW,BBG00BWQPDY9,Edited Transcript of AVXS earnings conference call or presentation 16-Mar-17 8:30pm GMT,2017-03-17 10:57:47 +0000,http://finance.yahoo.com/news/edited-transcript-avxs-earnings-conference-105747141.html,Edited Transcript of AVXS earnings conference call or presentation 16-Mar-17 8:30pm GMT
AVXS,AVXS:UW,BBG00BWQPDY9,"Futures Steady: 2 'A' Stocks Set To Soar, 1 Mule Ready To Kick",2017-03-17 04:02:22 +0000,http://finance.yahoo.com/r/d9f9443c-00ae-3d31-a499-4b3aba499f7e/dow-sp-500-futures-steady-2-a-stocks-set-to-soar-1-mule-ready-to-kick?src=A00220A&yptr=yahoo&.tsrc=rss,"Stock futures signaled little change, but Adobe and biotech AveXis should jump to highs, while MuleSoft IPO debuts."
AVXS,AVXS:UW,BBG00BWQPDY9,"Futures Steady: 2 'A' Stocks Set To Soar, 1 Mule Ready To Kick",2017-03-17 04:02:22 +0000,http://www.investors.com/market-trend/stock-market-today/dow-sp-500-futures-steady-2-a-stocks-set-to-soar-1-mule-ready-to-kick/?src=A00220A,"Futures Steady: 2 'A' Stocks Set To Soar, 1 Mule Ready To Kick"
AVXS,AVXS:UW,BBG00BWQPDY9,"AVXS Abuzz, PTCT Slammed For Emflaza Deal, INNL Scouts For Buyer",2017-03-17 02:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bxNIUdejHpo/avxs-abuzz-ptct-slammed-for-emflaza-deal-innl-scouts-for-buyer-20170317-00039,"AVXS Abuzz, PTCT Slammed For Emflaza Deal, INNL Scouts For Buyer"
AVXS,AVXS:UW,BBG00BWQPDY9,"After-hours buzz: ADBE, AVXS, GOOS & more",2017-03-16 21:51:57 +0000,http://www.cnbc.com/id/104346949?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104346949,[at CNBC] - See which stocks are posting big moves after the bell.
AVXS,AVXS:UW,BBG00BWQPDY9,"After-hours buzz: ADBE, AVXS, GOOS & more",2017-03-16 21:51:57 +0000,http://finance.yahoo.com/news/hours-buzz-adbe-avxs-goos-215157013.html?.tsrc=rss,See which stocks are posting big moves after the bell.
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis reports 4Q loss,2017-03-16 21:12:40 +0000,http://finance.yahoo.com/news/avexis-reports-4q-loss-211240704.html?.tsrc=rss,"On a per-share basis, the Bannockburn, Illinois-based company said it had a loss of 92 cents. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ..."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis reports 4Q loss,2017-03-16 21:12:40 +0000,http://finance.yahoo.com/news/avexis-reports-4q-loss-211240704.html,AveXis reports 4Q loss
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Inc Earnings Call scheduled for 4:30 pm ET today,2017-03-16 20:30:00 +0000,http://biz.yahoo.com/cc/8/156078.html,AveXis Inc Earnings Call scheduled for 4:30 pm ET today
AVXS,AVXS:UW,BBG00BWQPDY9,"AVEXIS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial S",2017-03-16 20:21:40 +0000,http://biz.yahoo.com/e/170316/avxs8-k.html,"AVEXIS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial S"
AVXS,AVXS:UW,BBG00BWQPDY9,4:08 pm AveXis misses by $0.19; reports topline results from the Phase 1 trial of AVXS-101 in SMA Type 1,2017-03-16 20:08:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#avxs,4:08 pm AveXis misses by $0.19; reports topline results from the Phase 1 trial of AVXS-101 in SMA Type 1
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Reports Topline Results from Phase 1 Trial of AVXS-101 in SMA Type 1 and Fourth Quarter and Full Year 2016 Financial and Operating Results,2017-03-16 20:05:00 +0000,http://finance.yahoo.com/news/avexis-reports-topline-results-phase-200500701.html?.tsrc=rss,–No new treatment-related safety or tolerability findings–– No new events reported and 15 of 15 patients event-free at 13.6 months of age; majority of patients receiving proposed therapeutic dose sit unassisted–– ...
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Reports Topline Results from Phase 1 Trial of AVXS-101 in SMA Type 1 and Fourth Quarter and Full Year 2016 Financial and Operating Results,2017-03-16 20:05:00 +0000,http://finance.yahoo.com/news/avexis-reports-topline-results-phase-200500701.html,[GlobeNewswire] - –No new treatment-related safety or tolerability findings–– No new events reported and 15 of 15 patients event-free at 13.6 months of age; majority of patients receiving proposed therapeutic dose sit unassisted–– ...
AVXS,AVXS:UW,BBG00BWQPDY9,"After-Hours Earnings Report for March 16, 2017 :  ADBE, AVXS, CAL, MG, OMER, PTCT, BTX, VSLR, CALA, VRAY, WLB, EXA",2017-03-16 18:52:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rPJGey0LdqE/after-hours-earnings-report-for-march-16-2017-adbe-avxs-cal-mg-omer-ptct-btx-vslr-cala-vray-wlb-exa-cm761835,The following companies are expected to report earnings after hours on 03 16 2017 Visit our Earnings Calendar for a full list of expected earnings releases Adobe Systems Incorporated ADBE is reporting for the quarter ending February 28 2017 The
AVXS,AVXS:UW,BBG00BWQPDY9,Q4 2016 AveXis Inc Earnings Release - After Market Close,2017-03-16 11:07:03 +0000,http://biz.yahoo.com/research/earncal/20170316.html?t=avxs,Q4 2016 AveXis Inc Earnings Release - After Market Close
AVXS,AVXS:UW,BBG00BWQPDY9,What's In Store For AVXS Today?,2017-03-16 05:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qhESsE5F0XA/whats-in-store-for-avxs-today-20170316-00169,What's In Store For AVXS Today?
AVXS,AVXS:UW,BBG00BWQPDY9,"5 Earnings Short-Squeeze Plays: Tiffany, Athene and More",2017-03-14 18:05:00 +0000,http://finance.yahoo.com/r/d41d09a4-cc70-3dad-8525-a90c775c79cc/5-earnings-short-squeeze-plays-tiffany-athene-and-more.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,These heavily shorted stocks could get squeezed higher if they report positive earnings this week.
AVXS,AVXS:UW,BBG00BWQPDY9,"5 Earnings Short-Squeeze Plays: Tiffany, Athene and More",2017-03-14 18:05:00 +0000,https://www.thestreet.com/story/14042475/1/5-earnings-short-squeeze-plays-tiffany-athene-and-more.html?puc=yahoo&cm_ven=YAHOO,"5 Earnings Short-Squeeze Plays: Tiffany, Athene and More"
AVXS,AVXS:UW,BBG00BWQPDY9,"Noteworthy Thursday Option Activity: AVXS, IBM, OMER",2017-03-09 18:12:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O9K5rYHraNg/noteworthy-thursday-option-activity-avxs-ibm-omer-cm758641,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in AveXis Inc Symbol AVXS where a total of 2 133 contracts have traded so far representing approximately 213 300 underlying shares That amounts to about 74 6 of AVXS s average
AVXS,AVXS:UW,BBG00BWQPDY9,Blog Coverage Heat Biologics Acquires Controlling Stake in Immuno-Oncology Company Pelican Therapeutics,2017-03-09 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-heat-biologics-acquires-131500148.html?.tsrc=rss,"Upcoming AWS Coverage on AveXis Post-Earnings Results LONDON, UK / ACCESSWIRE / March 9, 2017 / Active Wall St. blog coverage looks at the headline from Heat Biologics, Inc. (NASDAQ: HTBX ) (""Heat"") ..."
AVXS,AVXS:UW,BBG00BWQPDY9,Blog Coverage Heat Biologics Acquires Controlling Stake in Immuno-Oncology Company Pelican Therapeutics,2017-03-09 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-heat-biologics-acquires-131500148.html,"[Accesswire] - Upcoming AWS Coverage on AveXis Post-Earnings Results LONDON, UK / ACCESSWIRE / March 9, 2017 / Active Wall St. blog coverage looks at the headline from Heat Biologics, Inc. (NASDAQ: HTBX ) (""Heat"") ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"AveXis to Report Topline Phase 1 Trial Results in SMA Type 1 and Fourth Quarter and Full Year 2016 Financial and Operating Results on March 16, 2017",2017-03-09 13:00:00 +0000,http://finance.yahoo.com/news/avexis-report-topline-phase-1-130000878.html?.tsrc=rss,"--Conference call and webcast on March 16 at 4:30 p.m. EDT--. CHICAGO, March 09, 2017-- AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"AveXis to Report Topline Phase 1 Trial Results in SMA Type 1 and Fourth Quarter and Full Year 2016 Financial and Operating Results on March 16, 2017",2017-03-09 13:00:00 +0000,http://finance.yahoo.com/news/avexis-report-topline-phase-1-130000878.html,"[GlobeNewswire] - --Conference call and webcast on March 16 at 4:30 p.m. EDT--. CHICAGO, March 09, 2017-- AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening ..."
AVXS,AVXS:UW,BBG00BWQPDY9,Puma Leads Massive Biotech Surge As Esperion Hits 15-Month High,2017-03-08 21:26:56 +0000,http://www.investors.com/news/technology/puma-leads-massive-biotech-surge-as-esperion-hits-15-month-high/?src=A00220A,Puma Leads Massive Biotech Surge As Esperion Hits 15-Month High
AVXS,AVXS:UW,BBG00BWQPDY9,Puma Leads Massive Biotech Surge As Esperion Hits 15-Month High,2017-03-08 21:26:56 +0000,http://finance.yahoo.com/r/854c6c59-6440-3d2f-a760-5c994a4d9f36/puma-leads-massive-biotech-surge-as-esperion-hits-15-month-high?src=A00220A&yptr=yahoo&.tsrc=rss,"Esperion stock hit a 15-month high Wednesday on a broad biotech surge that saw Puma, AveXis and Bluebird leap."
AVXS,AVXS:UW,BBG00BWQPDY9,5 Things Biogen's CEO Just Said That You Don't Want to Miss,2017-03-07 23:14:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pa4DV7hwBJ0/5-things-biogens-ceo-just-said-that-you-dont-want-to-miss-cm757608,Despite headwinds for its multiple sclerosis MS franchise Biogen NASDAQ BIIB has been on a roll lately The biotech won U S regulatory approval for spinal muscular atrophy SMA drug Spinraza in December It also spun off its hemophilia business into a new company
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis to Present Results from Phase 1 Trial of AVXS-101 in SMA Type 1 at AAN Annual Meeting,2017-03-02 21:05:00 +0000,http://finance.yahoo.com/news/avexis-present-results-phase-1-210500463.html,"[GlobeNewswire] - CHICAGO, March 02, 2017-- AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced ..."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis to Present Results from Phase 1 Trial of AVXS-101 in SMA Type 1 at AAN Annual Meeting,2017-03-02 21:05:00 +0000,http://finance.yahoo.com/news/avexis-present-results-phase-1-210500463.html?.tsrc=rss,"CHICAGO, March 02, 2017-- AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"Boxer Capital, LLC Buys AveXis, BeiGene, Alnylam Pharmaceuticals, Sells Biomarin ...",2017-02-17 20:51:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XwYgiiI0jBI/boxer-capital-llc-buys-avexis-beigene-alnylam-pharmaceuticals-sells-biomarin-cm749825,Boxer Capital LLC New Purchases ALNY ALXN SBBP SNSS BLPH RXDX Added Positions AVXS BGNE MDCO Reduced Positions SGEN CLVS ARDM Sold Out BMRN RIGL HRTX EBIO EPIX New Purchases ALNY ALXN SBBP SNSS BLPH RXDX
AVXS,AVXS:UW,BBG00BWQPDY9,3 Stocks Setting Up for Major Breakouts,2017-02-17 19:26:00 +0000,http://finance.yahoo.com/r/3df4cabc-4f2c-3e95-a0bd-14bb9fc68be8/5-stocks-setting-up-for-major-breakouts.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here's how to rake in the gains off some potential major breakouts.
AVXS,AVXS:UW,BBG00BWQPDY9,3 Stocks Setting Up for Major Breakouts,2017-02-17 19:26:00 +0000,https://www.thestreet.com/story/14006716/1/5-stocks-setting-up-for-major-breakouts.html?puc=yahoo&cm_ven=YAHOO,3 Stocks Setting Up for Major Breakouts
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Appoints Rick Modi as Senior Vice President and Chief Business Officer,2017-02-15 13:00:00 +0000,http://finance.yahoo.com/news/avexis-appoints-rick-modi-senior-130000783.html?.tsrc=rss,"CHICAGO, Feb. 15, 2017-- AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced the ..."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Appoints Rick Modi as Senior Vice President and Chief Business Officer,2017-02-15 13:00:00 +0000,http://finance.yahoo.com/news/avexis-appoints-rick-modi-senior-130000783.html,"[GlobeNewswire] - CHICAGO, Feb. 15, 2017-- AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced the ..."
AVXS,AVXS:UW,BBG00BWQPDY9,Abeona: Preparing For Liftoff - The Next Avexis?,2017-02-14 15:18:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-b2MqGaF2SE/abeona-preparing-for-liftoff-the-next-avexis-cm747604,By World s Greatest ByWorld s Greatest Executive Summary and Investment Thesis Executive Summary and Investment ThesisExecutive Summary and Investment Thesis Abeona Therapeutics ABEO is a biotechnology company with a number of early and late stage assets This week the company
AVXS,AVXS:UW,BBG00BWQPDY9,"[$$] Venrock Refuels, and Goes Back on the Hunt",2017-02-09 23:53:18 +0000,https://www.wsj.com/articles/venrock-refuels-and-goes-back-on-the-hunt-1486684393?mod=yahoo_hs,"[$$] Venrock Refuels, and Goes Back on the Hunt"
AVXS,AVXS:UW,BBG00BWQPDY9,Chardan Analyst Suggests An AveXis-Ionis Pair Trade,2017-02-06 15:41:43 +0000,http://finance.yahoo.com/news/chardan-analyst-suggests-avexis-ionis-154143342.html,Chardan Analyst Suggests An AveXis-Ionis Pair Trade
AVXS,AVXS:UW,BBG00BWQPDY9,Health Care Sector Update for 02/06/2017: AVXS,2017-02-06 14:57:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9QFFEZeijMo/health-care-sector-update-for-02062017-avxs-cm743542,Top Health care stocks Top Health care stocks JNJ 0 3 JNJ 0 3 PFE 0 1 PFE 0 1 ABT flatABT flat MRK 0 5 MRK 0 5 AMGN 0 4 AMGN 0 4 Health care shares were mainly lower in pre market trade on Monday Health care shares were mainly lower in pre market trade on Monday
AVXS,AVXS:UW,BBG00BWQPDY9,"AVEXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-02-06 13:27:48 +0000,http://biz.yahoo.com/e/170206/avxs8-k.html,"AVEXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Announces Single-Arm Design for European Pivotal Study of AVXS-101 in SMA Type 1 Patients,2017-02-06 13:00:00 +0000,http://finance.yahoo.com/news/avexis-announces-single-arm-design-130000763.html,"[GlobeNewswire] - CHICAGO, Feb. 06, 2017-- AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced that ..."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Gene Therapy AVXS-101 Granted Access into EMA PRIME Program for Spinal Muscular Atrophy Type 1,2017-01-31 13:00:00 +0000,http://finance.yahoo.com/news/avexis-gene-therapy-avxs-101-130000117.html,"[GlobeNewswire] - CHICAGO, Jan. 31, 2017-- AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced that ..."
AVXS,AVXS:UW,BBG00BWQPDY9,Hurry! These 5 Stocks Are About to Break Out Explosively,2017-01-13 19:35:00 +0000,https://www.thestreet.com/story/13953629/1/5-stocks-setting-up-for-explosive-breakout-trades-including-gnc.html?puc=yahoo&cm_ven=YAHOO,Hurry! These 5 Stocks Are About to Break Out Explosively
AVXS,AVXS:UW,BBG00BWQPDY9,"AVEXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits",2017-01-09 14:16:59 +0000,http://biz.yahoo.com/e/170109/avxs8-k.html,"AVEXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits"
AVXS,AVXS:UW,BBG00BWQPDY9,Will 2017 IPO Market Revive After Dismal 2016?,2017-01-03 22:38:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zOuZiqbrD_s/will-2017-ipo-market-revive-after-dismal-2016-cm728948,Proceeds from the U S Initial Public Offerings IPOs slowed down in 2016 as 105 IPOs raised only 18 8 billion which was the lowest since 2003 Median deal size of 95 million remained below 100 million for the second consecutive year According to Renaissance Capital the primary
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis to Present at the 35th Annual J.P. Morgan Healthcare Conference,2017-01-03 13:00:00 +0000,http://finance.yahoo.com/news/avexis-present-35th-annual-j-130000612.html,"[GlobeNewswire] - CHICAGO, Jan. 03, 2017-- AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced Sean ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"Biotech's Top 3 Stock Losers, and Winners, in 2016",2016-12-30 19:23:00 +0000,http://www.forbes.com/sites/luketimmerman/2016/12/30/biotechs-top-3-stock-losers-and-winners-in-2016/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,"Biotech's Top 3 Stock Losers, and Winners, in 2016"
AVXS,AVXS:UW,BBG00BWQPDY9,"Top Analyst Upgrades and Downgrades: Biogen, Comerica, Deere, NVIDIA, 21st Century Fox and More",2016-12-29 14:25:38 +0000,http://247wallst.com/investing/2016/12/29/top-analyst-upgrades-and-downgrades-biogen-comerica-deere-nvidia21st-century-fox-and-more/,"Top Analyst Upgrades and Downgrades: Biogen, Comerica, Deere, NVIDIA, 21st Century Fox and More"
AVXS,AVXS:UW,BBG00BWQPDY9,Avexis Inc. (AVXS): RA Capital Management Ups Its Stake,2016-12-27 12:45:39 +0000,http://www.insidermonkey.com/blog/avexis-inc-avxs-ra-capital-management-ups-its-stake-513023/,Avexis Inc. (AVXS): RA Capital Management Ups Its Stake
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis to Use Intended Commercial GMP Product in SMA Type 2 Study,2016-12-21 22:12:08 +0000,http://www.publicnow.com/view/8D476982B5D6485B0B49F95ADD081079641AE260,"[at noodls] - - SMA Type 2 study to initiate in Q2 2017 - - Streamlines development of Type 2 clinical data set - - Conference call and webcast December 21, at 4:30 p.m. EST - CHICAGO, Dec. 21, 2016 (GLOBE NEWSWIRE) ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"AVEXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-12-21 21:08:03 +0000,http://biz.yahoo.com/e/161221/avxs8-k.html,"AVEXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
AVXS,AVXS:UW,BBG00BWQPDY9,3 Reasons Biogen Inc. Stock Is Set to Soar in 2017,2016-12-20 22:36:26 +0000,http://www.fool.com/investing/2016/12/20/3-reasons-biogen-inc-stock-is-set-to-soar-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Reasons Biogen Inc. Stock Is Set to Soar in 2017
AVXS,AVXS:UW,BBG00BWQPDY9,3 Reasons Biogen Inc. Stock Is Set to Soar in 2017,2016-12-20 21:57:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8slgPY6_Fy4/3-reasons-biogen-inc-stock-is-set-to-soar-in-2017-cm724261,It s looking like 2016 will turn out to be disappointing for Biogen NASDAQ BIIB shareholders Part of the stock s lackluster performance stemmed from a midstage clinical setback for experimental multiple sclerosis drug opicinumab The broader slowdown for biotech stocks was
AVXS,AVXS:UW,BBG00BWQPDY9,Citron Research On AveXis: This Will Be One Of 2017's Biotech Blowups,2016-12-15 16:03:24 +0000,http://finance.yahoo.com/news/citron-research-avexis-one-2017s-160324347.html,Citron Research On AveXis: This Will Be One Of 2017's Biotech Blowups
AVXS,AVXS:UW,BBG00BWQPDY9,Do Hedge Funds Love ClubCorp Holdings Inc (MYCC)?,2016-12-07 07:36:35 +0000,http://www.insidermonkey.com/blog/do-hedge-funds-love-clubcorp-holdings-inc-mycc-500334/,Do Hedge Funds Love ClubCorp Holdings Inc (MYCC)?
AVXS,AVXS:UW,BBG00BWQPDY9,3 Things You Need to Know About Ionis Pharmaceuticals' Pipeline,2016-12-02 13:03:04 +0000,http://www.fool.com/investing/2016/12/01/3-things-you-need-to-know-about-ionis-pharmaceutic.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Things You Need to Know About Ionis Pharmaceuticals' Pipeline
AVXS,AVXS:UW,BBG00BWQPDY9,3 Things You Need to Know About Ionis Pharmaceuticals' Pipeline,2016-12-01 14:17:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TeigZk1o1zc/3-things-you-need-to-know-about-ionis-pharmaceuticals-pipeline-cm716200,Few biotechs have as robust of a pipeline as Ionis Pharmaceuticals NASDAQ IONS The company has certainly experienced ups and downs in 2016 with its pipeline candidates but Ionis is ending the year on a good note Wade Walke vice president of corporate communications
AVXS,AVXS:UW,BBG00BWQPDY9,Ionis Pharmaceuticals Inc Back in the Black (for Now),2016-11-11 22:28:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fUqj3sxSNoQ/ionis-pharmaceuticals-inc-back-in-the-black-for-now-cm708133,Image source Getty Images Ionis Pharmaceuticals NASDAQ IONS reported third quarter earnings on Wednesday but investors are rightfully focused on the pending approval of Spinraza for spinal muscular atrophy SMA and its progressing pipeline Ionis Pharmaceuticals
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis reports 3Q loss,2016-11-10 22:02:28 +0000,http://sg.finance.yahoo.com/news/avexis-reports-3q-loss-220228251.html,AveXis reports 3Q loss
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Reports Third Quarter 2016 Financial and Operating Results,2016-11-10 21:11:13 +0000,http://www.publicnow.com/view/A5406A7D0F473A0545E50D4D4D5C6B3DD040526C,[at noodls] - - AVXS-101 demonstrated continued motor function improvement in ongoing study; majority of patients on proposed therapeutic dose achieved key developmental milestones - - Confirmed single-arm design for ...
AVXS,AVXS:UW,BBG00BWQPDY9,"AVEXIS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2016-11-10 21:07:12 +0000,http://biz.yahoo.com/e/161110/avxs8-k.html,"AVEXIS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
AVXS,AVXS:UW,BBG00BWQPDY9,Drug Stocks Surge on Trump Win: 5 Stocks to Buy Now,2016-11-10 15:56:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e8xd6YkfwdM/drug-stocks-surge-on-trump-win-5-stocks-to-buy-now-cm707089,The Presidential election is finally over and the stock market has reacted favorably to Donald Trump s surprise win with the S amp P 500 rising 1 1 the Dow Jones Industrial Average surging 1 4 and the NASDAQ gaining 1 1 Finance energy pharma biotech financial services
AVXS,AVXS:UW,BBG00BWQPDY9,Drug Stocks Surge on Trump Win: 5 Stocks to Buy Now,2016-11-10 13:31:01 +0000,http://finance.yahoo.com/news/drug-stocks-surge-trump-win-133101328.html,Drug Stocks Surge on Trump Win: 5 Stocks to Buy Now
AVXS,AVXS:UW,BBG00BWQPDY9,Q3 2016 AveXis Inc Earnings Release - After Market Close,2016-11-10 12:07:09 +0000,http://biz.yahoo.com/research/earncal/20161110.html?t=avxs,Q3 2016 AveXis Inc Earnings Release - After Market Close
AVXS,AVXS:UW,BBG00BWQPDY9,Should You Sell AveXis (AVXS) Before Earnings?,2016-11-09 17:55:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d5S2sV4m4oA/should-you-sell-avexis-avxs-before-earnings-cm706575,Investors are always looking for stocks that are poised to beat at earnings season and AveXis Inc AVXS may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because AveXisis seeing favorable earnings
AVXS,AVXS:UW,BBG00BWQPDY9,Teva (TEVA): Can it Keep the Earnings Streak Alive in Q3?,2016-11-09 16:56:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/83DGZSqKNog/teva-teva-can-it-keep-the-earnings-streak-alive-in-q3-cm706520,Teva Pharmaceutical Industries Ltd TEVA will be reporting third quarter 2016 earnings on Nov 15 before market open Last quarter the company delivered a positive earnings surprise of 5 93 The generic drug maker has been consistently beating earnings expectations The company s
AVXS,AVXS:UW,BBG00BWQPDY9,Should You Sell AveXis (AVXS) Before Earnings?,2016-11-09 15:36:03 +0000,http://finance.yahoo.com/news/sell-avexis-avxs-earnings-153603048.html,Should You Sell AveXis (AVXS) Before Earnings?
AVXS,AVXS:UW,BBG00BWQPDY9,"Drug Stocks Q3 Earnings Roster for Nov 10: AVXS, GBT & BPMC",2016-11-09 13:10:01 +0000,http://finance.yahoo.com/news/drug-stocks-q3-earnings-roster-131001723.html,"Drug Stocks Q3 Earnings Roster for Nov 10: AVXS, GBT & BPMC"
AVXS,AVXS:UW,BBG00BWQPDY9,Adverum (ADVM) Q3 Earnings Preview: What's in the Cards?,2016-11-08 18:33:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pq-qRep56m0/adverum-advm-q3-earnings-preview-whats-in-the-cards-cm705445,Adverum Biotechnologies Inc ADVM is expected to report third quarter 2016 results on Nov 14 In the last reported quarter Adverum posted a positive surprise of 5 26 Adverum has a dismal track record with the company missing estimates in three of the last four quarters bringing
AVXS,AVXS:UW,BBG00BWQPDY9,"Spinal Muscular Atrophy in Focus as Biogen, IONS Shoot Up on Data",2016-11-08 13:19:01 +0000,http://finance.yahoo.com/news/spinal-muscular-atrophy-focus-biogen-131901364.html,"Spinal Muscular Atrophy in Focus as Biogen, IONS Shoot Up on Data"
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis to Present at Jefferies 2016 London Healthcare Conference,2016-11-08 13:00:00 +0000,http://finance.yahoo.com/news/avexis-present-jefferies-2016-london-130000325.html,"[GlobeNewswire] - CHICAGO, Nov. 08, 2016-- AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced that ..."
AVXS,AVXS:UW,BBG00BWQPDY9,Immune Design (IMDZ): Stock to Disappoint in Q3 Earnings?,2016-11-08 00:53:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e3YoJaB6ZL4/immune-design-imdz-stock-to-disappoint-in-q3-earnings-cm705326,Immune Design Corp IMDZ is scheduled to report third quarter 2016 results after the market closes on Nov 9 In the last reported quarter Immune Design posted a negative surprise of 4 41 The company reported a wider than expected loss in two of the four trailing quarters and
AVXS,AVXS:UW,BBG00BWQPDY9,Catalyst Pharma (CPRX) Q3 Earnings: Will Stock Surprise?,2016-11-07 16:02:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tNcJDvIAfSE/catalyst-pharma-cprx-q3-earnings-will-stock-surprise-cm704908,Catalyst Pharmaceuticals Inc CPRX is scheduled to report third quarter 2016 results on Nov 9 after market close Last quarter the company s loss was narrower than expected Catalyst s performance so far has been mixed The company beat expectations in two of the last four quarters
AVXS,AVXS:UW,BBG00BWQPDY9,Can The Uptrend Continue for AveXis (AVXS)?,2016-11-04 14:13:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZT-ALBExcJU/can-the-uptrend-continue-for-avexis-avxs-cm704042,Investors certainly have to be happy with AveXis Inc AVXS and its short term performance After all the stock has jumped by 33 2 in the past 4 weeks and it is also above its 20 Day Simple Moving Average as well This is certainly a good trend but investors are probably asking
AVXS,AVXS:UW,BBG00BWQPDY9,Can The Uptrend Continue for AveXis (AVXS)?,2016-11-04 13:20:01 +0000,http://finance.yahoo.com/news/uptrend-continue-avexis-avxs-132001904.html,Can The Uptrend Continue for AveXis (AVXS)?
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Inc (AVXS): Of Course The FDA Didn’t Ask For Placebo Data,2016-11-03 16:09:30 +0000,http://www.insidermonkey.com/blog/avexis-inc-avxs-of-course-the-fda-didnt-ask-for-placebo-data-484792/,AveXis Inc (AVXS): Of Course The FDA Didn’t Ask For Placebo Data
AVXS,AVXS:UW,BBG00BWQPDY9,"CEMP Loses Big As D-Day Nears, AVXS Catches Investors'' Eyes, No Respite For OPXA",2016-11-03 02:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HYQ7fJGCKSc/cemp-loses-big-as-dday-nears-avxs-catches-investors-eyes-no-respite-for-opxa-20161103-00039,"CEMP Loses Big As D-Day Nears, AVXS Catches Investors'' Eyes, No Respite For OPXA"
AVXS,AVXS:UW,BBG00BWQPDY9,Here's Why AveXis Shot Up 24.5% Today,2016-11-02 19:08:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pB5GXe981gQ/heres-why-avexis-shot-up-245-today-cm702731,Image source Getty Images What happened Shares of AveXis NASDAQ AVXS were up over 24 today after the gene therapy biopharma announced 160 plans for a single arm design for a trial to evaluate its leading drug candidate against spinal muscular atrophy or SMA So
AVXS,AVXS:UW,BBG00BWQPDY9,Here's Why AveXis Shot Up 24.5% Today,2016-11-02 17:41:18 +0000,http://www.fool.com/investing/2016/11/02/heres-why-avexis-shot-up-245-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why AveXis Shot Up 24.5% Today
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Announces Single-Arm Design for U.S. Pivotal Study of AVXS-101 in SMA Type 1 Patients,2016-11-01 20:16:10 +0000,http://www.publicnow.com/view/772AEF35308409F017D80CDF84216624D38CE9C6,"[at noodls] - - Company provides update following receipt of FDA minutes from Type B meeting - - Conference call and webcast November 1 at 4:30 p.m. EDT - CHICAGO, Nov. 01, 2016 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ:AVXS), ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"AVEXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-11-01 20:10:40 +0000,http://biz.yahoo.com/e/161101/avxs8-k.html,"AVEXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
AVXS,AVXS:UW,BBG00BWQPDY9,Humana (HUM) Likely to Top Q3 Earnings; Stock to Gain?,2016-11-01 17:16:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AqKSgcF0hec/humana-hum-likely-to-top-q3-earnings-stock-to-gain-cm701897,We expect 160 Humana Inc HUM to beat expectations when it reports third quarter results on Nov 4 before the market opens Why a Likely Positive Surprise Our proven model shows that Humana has the right combination of two key ingredients to beat estimates Zacks
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis to Report Third Quarter 2016 Financial and Operating Results,2016-10-31 12:13:08 +0000,http://www.publicnow.com/view/89D882294803E6B4C9690888AFEBB449BCD7B7EA,"[at noodls] - CHICAGO, Oct. 31, 2016 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ:AVXS), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"If you want to know which way the market is heading, follow the leaders",2016-10-17 18:27:35 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=289AC500-4ED1-46ED-917B-0402209CE1BC&siteid=yhoof2,"If you want to know which way the market is heading, follow the leaders"
AVXS,AVXS:UW,BBG00BWQPDY9,Is AveXis a Major Threat to Ionis Pharmaceuticals?,2016-10-14 13:43:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bnW__aKfJbI/is-avexis-a-major-threat-to-ionis-pharmaceuticals-cm693302,Image source AveXis Inc Shares of 160 Ionis Pharmaceuticals Inc NASDAQ IONS 160 have lost about 12 1 of their value since AveXis Inc NASDAQ AVXS shared early evidence that its gene therapy benefited infants with spinal muscular atrophy SMA One of the
AVXS,AVXS:UW,BBG00BWQPDY9,Is AveXis a Major Threat to Ionis Pharmaceuticals?,2016-10-14 11:44:19 +0000,http://www.fool.com/investing/2016/10/14/is-avexis-a-major-threat-to-ionis-pharmaceuticals.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is AveXis a Major Threat to Ionis Pharmaceuticals?
AVXS,AVXS:UW,BBG00BWQPDY9,"AVEXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits",2016-10-11 20:32:16 +0000,http://biz.yahoo.com/e/161011/avxs8-k.html,"AVEXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits"
AVXS,AVXS:UW,BBG00BWQPDY9,Biogen Gets Competition for SMA Therapy (BIIB),2016-10-11 19:40:00 +0000,http://www.investopedia.com/news/biogen-gets-competition-sma-therapy-biib/?partner=YahooSA,Biogen Gets Competition for SMA Therapy (BIIB)
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis to Host Webcast Update of Data from Ongoing Phase 1 Clinical Trial of AVXS-101 in Spinal Muscular Atrophy Type 1,2016-10-10 11:13:09 +0000,http://www.publicnow.com/view/14AAFD4250823B439D3913D5C7170EEC02190C11,"[at noodls] - -- Data, Including Developmental Milestones, as of September 15, 2016 as presented by Jerry Mendell, M.D. at the International Annual Congress of the World Muscle Society -- -- Webcast Today, October 10, ..."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Reports Interim Data from Ongoing Phase 1 Clinical Trial of AVXS-101 in Spinal Muscular Atrophy Type 1 as Presented at the International Annual Congress of the World Muscle Society,2016-10-08 13:23:05 +0000,http://www.publicnow.com/view/7754BE1DCC311A76CE143AD65CAA573C407B320C,[at noodls] - -- Majority of patients on the proposed therapeutic dose achieved key developmental milestones including sitting unassisted; two patients walking independently -- -- Conference call and webcast October ...
AVXS,AVXS:UW,BBG00BWQPDY9,Video Stock Market Analysis 10/7/16,2016-10-07 20:55:08 +0000,http://finance.yahoo.com/tumblr/blog-video-stock-market-analysis-10716-205513362.html,Video Stock Market Analysis 10/7/16
AVXS,AVXS:UW,BBG00BWQPDY9,A Few Recent IPOs that I am Watching,2016-10-03 15:19:47 +0000,http://finance.yahoo.com/tumblr/blog-a-few-recent-ipos-that-i-am-watching-151949097.html,A Few Recent IPOs that I am Watching
AVXS,AVXS:UW,BBG00BWQPDY9,Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy This Week,2016-09-28 14:35:59 +0000,http://247wallst.com/healthcare-business/2016/09/28/red-hot-biotechs-highlight-jefferies-top-stocks-to-buy-this-week/,Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy This Week
AVXS,AVXS:UW,BBG00BWQPDY9,[$$] Abeona Expands Opportunity With Partnerships,2016-09-23 20:08:00 +0000,http://www.barrons.com/articles/abeona-expands-opportunity-with-partnerships-1474661316?mod=yahoobarrons&ru=yahoo,[$$] Abeona Expands Opportunity With Partnerships
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis (AVXS) Shows Strength: Stock Adds 6.3% in Session,2016-09-20 14:24:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CgI5Zey7kM0/avexis-avxs-shows-strength-stock-adds-63-in-session-cm681867,AveXis Inc AVXS was a big mover last session as its shares rose a little over 6 on the day The move came on solid volume too with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above the volatile price
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis (AVXS) Shows Strength: Stock Adds 6.3% in Session,2016-09-20 12:25:12 +0000,http://finance.yahoo.com/news/avexis-avxs-shows-strength-stock-122512922.html,AveXis (AVXS) Shows Strength: Stock Adds 6.3% in Session
AVXS,AVXS:UW,BBG00BWQPDY9,"[$$] Nationwide Children's Hospital, Rev1 Form Seed Fund",2016-09-20 11:30:31 +0000,http://www.wsj.com/articles/nationwide-childrens-hospital-rev1-form-seed-fund-1474371009?mod=yahoo_hs,"[$$] Nationwide Children's Hospital, Rev1 Form Seed Fund"
AVXS,AVXS:UW,BBG00BWQPDY9,These 7 Stocks Are Spiking on Big Volume,2016-09-09 12:24:00 +0000,https://www.thestreet.com/story/13699697/1/these-7-stocks-are-spiking-on-big-volume.html?puc=yahoo&cm_ven=YAHOO,These 7 Stocks Are Spiking on Big Volume
AVXS,AVXS:UW,BBG00BWQPDY9,"Pre-Market Most Active for Sep 8, 2016 :  TWTR, RAD, AZN, SMFG, AMH, SNY, AAPL, TSCO, QQQ, SUNS, TVIX, AVXS",2016-09-08 12:57:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hEANc_Mec_A/pre-market-most-active-for-sep-8-2016-twtr-rad-azn-smfg-amh-sny-aapl-tsco-qqq-suns-tvix-avxs-cm676094,The NASDAQ 100 Pre Market Indicator is down 2 55 to 4 829 31 The total Pre Market volume is currently 11 167 721 shares traded The following are the most active stocks for the pre market session Twitter Inc TWTR is 1 02 at 18 85 with 2 270 297 shares traded TWTR
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Announces Pricing of Public Offering of Common Stock,2016-09-08 12:09:07 +0000,http://www.publicnow.com/view/64D7107E91F192AB062728A575439C9BD804E25F,"[at noodls] - CHICAGO, Sept. 08, 2016 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ:AVXS) today announced the pricing of an underwritten public offering of 4,250,000 shares of its common stock, 3,960,145 shares of which ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"Health Care Sector Update for 09/07/2016: AVXS,RTRX,ADPT",2016-09-07 16:57:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fUyFW1KuUi8/health-care-sector-update-for-09072016-avxsrtrxadpt-cm675742,Top Health Care StocksTop Health Care Stocks JNJ 0 03 JNJ 0 03 PFE 0 00 PFE 0 00 MRK 0 72 MRK 0 72 ABT 0 33 ABT 0 33 AMGN 0 12 AMGN 0 12 Health care stocks were little changed in recent trading Wednesday with the NYSE Health Care Index falling about 0 1 while shares of health
AVXS,AVXS:UW,BBG00BWQPDY9,"AVEXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-09-07 11:03:38 +0000,http://biz.yahoo.com/e/160907/avxs8-k.html,"AVEXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
AVXS,AVXS:UW,BBG00BWQPDY9,"AveXis Announces Proposed Public Offering of 4,000,000 Shares of Common Stock",2016-09-06 20:09:01 +0000,http://www.publicnow.com/view/35624A85C03E526082E6DE29282826AA56C0D047,"[at noodls] - CHICAGO, Sept. 06, 2016 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ:AVXS) today announced that it intends to offer and sell, subject to market conditions, 3,566,474 shares of its common stock in an underwritten ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"Street Talk: CREE, AAP & more",2016-08-17 18:49:00 +0000,http://finance.yahoo.com/video/street-talk-cree-aap-more-184900116.html,"Street Talk: CREE, AAP & more"
AVXS,AVXS:UW,BBG00BWQPDY9,RA Capital’s Top Q2 Performers; Predicts Big Things Ahead for Pharma Stocks,2016-08-17 13:33:10 +0000,http://www.insidermonkey.com/blog/ra-capitals-top-q2-performers-predicts-big-things-ahead-for-pharma-stocks-469435/,RA Capital’s Top Q2 Performers; Predicts Big Things Ahead for Pharma Stocks
AVXS,AVXS:UW,BBG00BWQPDY9,Top Biotechs Are Among Jefferies Growth Stock Favorites,2016-08-15 14:20:29 +0000,http://247wallst.com/investing/2016/08/15/top-biotechs-are-among-jefferies-growth-stock-favorites/,Top Biotechs Are Among Jefferies Growth Stock Favorites
AVXS,AVXS:UW,BBG00BWQPDY9,Analysts Are Bullish On These 5 Stocks That Went Public This Year,2016-08-13 12:54:30 +0000,http://finance.yahoo.com/news/analysts-bullish-5-stocks-went-125430038.html,Analysts Are Bullish On These 5 Stocks That Went Public This Year
AVXS,AVXS:UW,BBG00BWQPDY9,"AVEXIS, INC. Files SEC form 10-Q, Quarterly Report",2016-08-12 20:05:07 +0000,http://biz.yahoo.com/e/160812/avxs10-q.html,"AVEXIS, INC. Files SEC form 10-Q, Quarterly Report"
AVXS,AVXS:UW,BBG00BWQPDY9,"Street Talk: UA, BBRY & more",2016-08-12 18:45:00 +0000,http://finance.yahoo.com/video/street-talk-ua-bbry-more-184500373.html,"Street Talk: UA, BBRY & more"
AVXS,AVXS:UW,BBG00BWQPDY9,Edited Transcript of AVXS earnings conference call or presentation 11-Aug-16 8:30pm GMT,2016-08-12 03:36:45 +0000,http://finance.yahoo.com/news/edited-transcript-avxs-earnings-conference-033645657.html,Edited Transcript of AVXS earnings conference call or presentation 11-Aug-16 8:30pm GMT
AVXS,AVXS:UW,BBG00BWQPDY9,"AVXS Walks The Talk, AGN Opens Wallet, Zika Virus Data Lifts AEMD",2016-08-12 01:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xR3cLWnXEIc/avxs-walks-the-talk-agn-opens-wallet-zika-virus-data-lifts-aemd-20160812-00017,"AVXS Walks The Talk, AGN Opens Wallet, Zika Virus Data Lifts AEMD"
AVXS,AVXS:UW,BBG00BWQPDY9,"AVXS Walks The Talk, AGN Opens Wallet, Zika Virus Data Lifts AEMD",2016-08-12 01:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W4VOFMRrPOQ/avxs-walks-the-talk-agn-opens-wallet-zika-virus-data-lifts-aemd-20160812-00018,"AVXS Walks The Talk, AGN Opens Wallet, Zika Virus Data Lifts AEMD"
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis reports 2Q loss,2016-08-11 20:36:06 +0000,http://sg.finance.yahoo.com/news/avexis-reports-2q-loss-203606614.html,AveXis reports 2Q loss
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Reports Second Quarter 2016 Financial and Operating Results and Interim Data from Ongoing Phase 1 Trial of AVXS-101 in Spinal Muscular Atrophy Type 1,2016-08-11 20:21:02 +0000,http://www.publicnow.com/view/36EED175E40A66D5BF76A4AE5066CEC417138A1A,[at noodls] - -- Interim data through July 1 showed no 'events' -- -- Continued motor function improvement with 25% of patients in the proposed therapeutic dose group in the normal range -- -- FDA requested Type B Meeting ...
AVXS,AVXS:UW,BBG00BWQPDY9,"AVEXIS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial S",2016-08-11 20:09:41 +0000,http://biz.yahoo.com/e/160811/avxs8-k.html,"AVEXIS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial S"
AVXS,AVXS:UW,BBG00BWQPDY9,Q2 2016 AveXis Inc Earnings Release - After Market Close,2016-08-11 11:07:04 +0000,http://biz.yahoo.com/research/earncal/20160811.html?t=avxs,Q2 2016 AveXis Inc Earnings Release - After Market Close
AVXS,AVXS:UW,BBG00BWQPDY9,Why AveXis (AVXS) Might Surprise This Earnings Season,2016-08-09 14:39:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-_YxVdGv8ic/why-avexis-avxs-might-surprise-this-earnings-season-cm662435,"Investors are always looking for stocks that are poised to beat at earnings season and AveXis, Inc.AVXS may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their"
AVXS,AVXS:UW,BBG00BWQPDY9,Why AveXis (AVXS) Might Surprise This Earnings Season,2016-08-09 12:48:12 +0000,http://finance.yahoo.com/news/why-avexis-avxs-might-surprise-124812142.html,Why AveXis (AVXS) Might Surprise This Earnings Season
AVXS,AVXS:UW,BBG00BWQPDY9,What's in Store for Adverum (ADVM) this Earnings Season?,2016-08-08 17:16:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vlZ5R1WvioQ/whats-in-store-for-adverum-advm-this-earnings-season-cm661931,"Adverum Biotechnologies, Inc . ADVM is expected to report second quarter 2016 results on Aug 11. Adverum has a dismal track record with the company missing estimates in all of the last four quarters, bringing the negative average earnings"
AVXS,AVXS:UW,BBG00BWQPDY9,The Race To Cure Spinal Muscular Atrophy,2016-08-05 06:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oFrvWa6kz24/the-race-to-cure-spinal-muscular-atrophy-20160805-00108,The Race To Cure Spinal Muscular Atrophy
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis to Report Second Quarter 2016 Financial and Operating Results and Interim Data from Ongoing Phase 1 Trial of AVXS-101 in Spinal Muscular Atrophy Type 1,2016-08-02 12:11:13 +0000,http://www.publicnow.com/view/E308E393677E3B72D1DC824459D126925BF8FCC3,"[at noodls] - CHICAGO, Aug. 02, 2016 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ:AVXS), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic ..."
AVXS,AVXS:UW,BBG00BWQPDY9,Vishay Intertechnology Q2 16 Earnings Conference Call At 9:00 AM ET,2016-08-02 08:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b7i9XG_tRe8/vishay-intertechnology-q2-16-earnings-conference-call-at-900-am-et-20160802-00494,Vishay Intertechnology Q2 16 Earnings Conference Call At 9:00 AM ET
AVXS,AVXS:UW,BBG00BWQPDY9,"Ionis Childhood Spine Disorder Drug Notches Pivotal Study Win, Triggers Biogen Option",2016-08-01 16:51:00 +0000,https://www.thestreet.com/story/13659040/1/ionis-childhood-spine-disorder-drug-notches-pivotal-study-win-triggers-biogen-option.html?puc=yahoo&cm_ven=YAHOO,"Ionis Childhood Spine Disorder Drug Notches Pivotal Study Win, Triggers Biogen Option"
AVXS,AVXS:UW,BBG00BWQPDY9,Bigger and better: 2016 IPOs that raised more than $100 million are up over 30%,2016-07-22 23:07:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P4CrUASXu84/bigger-and-better-2016-ipos-that-raised-more-than-100-million-are-up-over-30-cm653642,"The 21 IPOs this year that have raised raised over $100 million have delivered investors an average return of 32%, including a first day pop of 14% and an additional 14% in the aftermarket. Most notably, only one IPO"
AVXS,AVXS:UW,BBG00BWQPDY9,"AVXS Making News For The Right Reasons, ONVO Pushing Ahead, XOMA Rises 14%",2016-07-21 00:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZV_fQGbrPHM/avxs-making-news-for-the-right-reasons-onvo-pushing-ahead-xoma-rises-14-20160721-00005,"AVXS Making News For The Right Reasons, ONVO Pushing Ahead, XOMA Rises 14%"
AVXS,AVXS:UW,BBG00BWQPDY9,"Health Care Sector Update for 07/20/2016: AVXS,PGNX,ZFGN",2016-07-20 20:26:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n9JU9N74aJA/health-care-sector-update-for-07202016-avxspgnxzfgn-cm652173,"Top Health Care Stocks JNJ +0.10% PFE +0.29% MRK +2.34% ABT +0.43% AMGN +0.52% Health care stocks were mostly higher today, with the NYSE Health Care Index posting a 0.9% gain while shares of health care companies in the"
AVXS,AVXS:UW,BBG00BWQPDY9,"Wednesday Sector Leaders: Biotechnology, Drugs",2016-07-20 16:10:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5j_YrqJmcy4/wednesday-sector-leaders-biotechnology-drugs-cm651949,"In trading on Wednesday, biotechnology shares were relative leaders, up on the day by about 1.9%. Leading the group were shares of Kura Oncology ( KURA ), up about 10.6% and shares of AveXis ( AVXS ) up about"
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Gets FDA Breakthrough Therapy Status For AVXS-101 Gene Replacement Therapy,2016-07-20 14:39:54 +0000,http://finance.yahoo.com/news/avexis-gets-fda-breakthrough-therapy-143954503.html,AveXis Gets FDA Breakthrough Therapy Status For AVXS-101 Gene Replacement Therapy
AVXS,AVXS:UW,BBG00BWQPDY9,"AVEXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-07-20 11:16:18 +0000,http://biz.yahoo.com/e/160720/avxs8-k.html,"AVEXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Receives U.S. FDA Breakthrough Therapy Designation for AVXS-101 Gene Replacement Therapy for Spinal Muscular Atrophy Type 1,2016-07-20 11:00:00 +0000,http://finance.yahoo.com/news/avexis-receives-u-fda-breakthrough-110000657.html,"[GlobeNewswire] - CHICAGO, July 20, 2016-- AveXis, Inc., a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced the ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"AveXis Appoints Michael B. Johannesen as Senior Vice President, General Counsel and Chief Compliance Officer",2016-07-11 12:13:09 +0000,http://www.publicnow.com/view/7564C390529FC4420911075304BAAB5779A4CE10,"[at noodls] - CHICAGO, July 11, 2016 (GLOBE NEWSWIRE) -- AveXis, Inc. (Nasdaq:AVXS), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"AVEXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers",2016-06-24 21:16:42 +0000,http://biz.yahoo.com/e/160624/avxs8-k.html,"AVEXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers"
AVXS,AVXS:UW,BBG00BWQPDY9,"Analysts' Actions -- Domino's, McDonald's, Priceline, Tesla and More",2016-06-22 12:07:00 +0000,http://finance.yahoo.com/news/analysts-actions-dominos-mcdonalds-priceline-120700817.html,"Analysts' Actions -- Domino's, McDonald's, Priceline, Tesla and More"
AVXS,AVXS:UW,BBG00BWQPDY9,These 5 Stocks Are Poised for Breakouts,2016-06-10 13:33:00 +0000,https://www.thestreet.com/story/13603660/1/these-5-stocks-are-poised-for-breakouts.html?puc=yahoo&cm_ven=YAHOO,These 5 Stocks Are Poised for Breakouts
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis to Present at Goldman Sachs Annual Global Healthcare Conference and Jefferies 2016 Healthcare Conference,2016-06-06 21:18:06 +0000,http://www.publicnow.com/view/F9AFFE924403E5F1EDA3A457DF26DF1E20A3AFF2,"[at noodls] - CHICAGO, June 06, 2016 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ:AVXS), a clinical-stage gene therapy company developing novel treatments for patients suffering from rare and life-threatening neurological ..."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis (AVXS) is in Overbought Territory: What's Next?,2016-06-02 16:57:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cJJ131nLrJw/avexis-avxs-is-in-overbought-territory-whats-next-cm629618,"AveXis, Inc.AVXS has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because AVXS is now in overbought territory with an RSI value of 75.48. What is RSI?        "
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis (AVXS) is in Overbought Territory: What's Next?,2016-06-02 15:04:03 +0000,http://finance.yahoo.com/news/avexis-avxs-overbought-territory-whats-150403414.html,AveXis (AVXS) is in Overbought Territory: What's Next?
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis (AVXS) Looks Good: Stock Adds 6.5% in Session,2016-06-02 14:59:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g9oNsS5vsIo/avexis-avxs-looks-good-stock-adds-65-in-session-cm629489,"AveXis, Inc.AVXS was a big mover last session, as the company saw its shares above 6% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This continues the"
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Presents Pulmonary Data from Ongoing Phase 1 Trial of AVXS-101 in Spinal Muscular Atrophy Type 1,2016-05-16 12:32:07 +0000,http://www.publicnow.com/view/B28C7FC5036DBA6917902C13ECC7CD3F6D916A84,"[at noodls] - CHICAGO, May 16, 2016 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ:AVXS), a clinical-stage gene therapy company developing novel treatments for patients suffering from rare and life-threatening neurological ..."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Reports First Quarter 2016 Financial and Operating Results,2016-05-12 21:27:14 +0000,http://www.publicnow.com/view/2A2623E8151E090944E659AE64FFD103AE98FCDA,"[at noodls] - Encouraging interim data for lead clinical program, AVXS-101, for Spinal Muscular Atrophy Type 1 Conference call May 12 at 4:30 p.m. EDT CHICAGO, May 12, 2016 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ:AVXS), ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"AveXis (AVXS) Shares March Higher, Can It Continue?",2016-05-12 16:29:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NyPJiJr90GE/avexis-avxs-shares-march-higher-can-it-continue-cm620245,"As of late, it has definitely been a great time to be an investor in AveXis, Inc.AVXS . The stock has moved higher by 55.2% in the past month, while it is also above its 20 Day SMA too."
AVXS,AVXS:UW,BBG00BWQPDY9,"Monday Sector Leaders: Drugs, Biotechnology Stocks",2016-05-09 17:16:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v-i_mRn5KZk/monday-sector-leaders-drugs-biotechnology-stocks-cm618365,"In trading on Monday, drugs shares were relative leaders, up on the day by about 2.6%. Leading the group were shares of Argos Therapeutics, up about 23.1% and shares of Eagle Pharmaceuticals up about 18.7% on the day."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis Reports Data from Ongoing Phase 1 Trial of AVXS-101 in Spinal Muscular Atrophy Type 1,2016-05-06 19:34:07 +0000,http://www.publicnow.com/view/754086F1A35DD2A48739A8D2606A9CA80DA5BF03,"[at noodls] - -- Jerry Mendell, MD, Presented Data as of April 1, 2016 at the American Society of Gene & Cell Therapy 19 Annual Meeting -- -- Company to Host Webcast Today at 4:30 p.m. Eastern Daylight Time -- CHICAGO, ..."
AVXS,AVXS:UW,BBG00BWQPDY9,"AveXis to Report First Quarter 2016 Financial Results on Thursday, May 12",2016-05-05 12:21:05 +0000,http://www.publicnow.com/view/75D6094B4A93818B9028ED68252ACEEDE09C77C8,"[at noodls] - CHICAGO, May 05, 2016 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ:AVXS), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic ..."
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis to Report Data from Ongoing Phase 1 Clinical Trial of AVXS-101 in Spinal Muscular Atrophy Type 1,2016-04-25 14:14:03 +0000,http://www.publicnow.com/view/17D5CDE73600259448C851C06546DB6C9AD8794E,"[at noodls] - -- Jerry Mendell, M.D., to Present Data as of April 1, 2016 at the American Society of Gene & Cell Therapy 19th Annual Meeting -- -- Company to Host Webcast on Friday, May 6, 2016 at 4:30 p.m. Eastern ..."
AVXS,AVXS:UW,BBG00BWQPDY9,Renaissance Capital's 1Q16 US IPO Market Review,2016-04-01 22:28:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nVgjwiVumJY/renaissance-capitals-1q16-us-ipo-market-review-cm598858,"The US IPO market in the 1Q16 hit its lowest levels since the depths of the financial crisis in 2008 2009. Not a single deal priced outside of the health care sector, where eight deals managed to raise $0.7"
AVXS,AVXS:UW,BBG00BWQPDY9,Cracks in the market bring SPACs to the market: Fun facts about SPACs,2016-03-06 09:38:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AT-FunnOueY/cracks-in-the-market-bring-spacs-to-the-market-fun-facts-about-spacs-cm585704,"Blank check company Silver Run Acquisition ( SRAQU ) made headlines in the IPO market   partly because little else could   as it completed the year's largest ""IPO"" in an upsized $450 million offering."
AVXS,AVXS:UW,BBG00BWQPDY9,US IPO Weekly Recap: IPO market largely closed; two biotechs go public and break,2016-02-16 14:47:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zuWVvH3YkPk/us-ipo-weekly-recap-ipo-market-largely-closed-two-biotechs-go-public-and-break-cm579553,"The IPO market was poised to raise $1.4 billion from four IPOs this past week, but instead two biotechs raised $145 million. A substantial portion of those proceeds came from insiders, and both biotechs broke issue with an average"
AVXS,AVXS:UW,BBG00BWQPDY9,Biotechs lean heavily on insider buying to complete quasi-IPOs,2016-02-12 17:47:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5ffWpYTO77I/biotechs-lean-heavily-on-insider-buying-to-complete-quasi-ipos-cm578796,"Accounting for 100% of the four IPOs so far this year, biotechs appeared to be the one sector able to generate demand from public investors. But demand is weaker than it seems. Of the nearly $400 million raised, insiders"
AVXS,AVXS:UW,BBG00BWQPDY9,AveXis prices upsized IPO at $20 midpoint,2016-02-11 00:35:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DTDsjyD75JE/avexis-prices-upsized-ipo-at-20-midpoint-cm578265,"AveXis, an early stage biotech developing a gene therapy for spinal muscular atrophy, raised $95 million in an upsized IPO by offering 4.75 million shares at $20, the midpoint of the range of $19 to $21. The company originally"
AVXS,AVXS:UW,BBG00BWQPDY9,Week ahead: Two large and levered IPOs take center stage to raise $1 billion,2016-02-06 05:13:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8rkYFCWXyhE/week-ahead-two-large-and-levered-ipos-take-center-stage-to-raise-1-billion-cm575836,"Two large and highly levered IPOs are scheduled to raise a combined $1 billion this week.On the go IPO ""Known as the company that put iPads in airports"", founder led OTG EXP ( OTG ) is looking to fuel its capital intensive"
